BGLAF.US Bangkok Life Assurance Public Company Limited

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
11.86 USD
Close of Nov 14, 2026
9.51 12.20
Market cap
USD 1.17B
P/E
28.2x
P/B
9.38x
ROE
32.0%
Dividend yield
1.51%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BGLAF.US undervalued?

Graham number

The Graham number of Bangkok Life Assurance Public Company Limited cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bangkok Life Assurance Public Company Limited fundamental analysis

No fundamental analysis for Bangkok Life Assurance Public Company Limited yet.

Bangkok Life Assurance Public Company Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bangkok Life Assurance Public Company Limited

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. I…

Full company profile